vs
Esperion Therapeutics, Inc.（ESPR）与UNITED STATES LIME & MINERALS INC（USLM）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是UNITED STATES LIME & MINERALS INC的1.9倍（$168.4M vs $87.9M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 9.8%），过去两年UNITED STATES LIME & MINERALS INC的营收复合增速更高（10.8% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
美国石灰矿产公司是总部位于美国的自然资源企业，主营高钙石灰、白云石石灰、石灰石及相关矿产制品，客户覆盖基建、钢铁制造、农业土壤改良、环保排放治理、工业加工等领域，业务主要辐射北美市场。
ESPR vs USLM — 直观对比
营收规模更大
ESPR
是对方的1.9倍
$87.9M
营收增速更快
ESPR
高出133.9%
9.8%
两年增速更快
USLM
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $87.9M |
| 净利润 | — | $30.5M |
| 毛利率 | — | 48.0% |
| 营业利润率 | 50.6% | 41.0% |
| 净利率 | — | 34.7% |
| 营收同比 | 143.7% | 9.8% |
| 净利润同比 | — | 13.2% |
| 每股收益（稀释后） | $0.32 | $1.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRUSLM
| Q4 25 | $168.4M | $87.9M | ||
| Q3 25 | $87.3M | $102.0M | ||
| Q2 25 | $82.4M | $91.5M | ||
| Q1 25 | $65.0M | $91.3M | ||
| Q4 24 | $69.1M | $80.1M | ||
| Q3 24 | $51.6M | $89.4M | ||
| Q2 24 | $73.8M | $76.5M | ||
| Q1 24 | $137.7M | $71.7M |
净利润ESPRUSLM
| Q4 25 | — | $30.5M | ||
| Q3 25 | $-31.3M | $38.8M | ||
| Q2 25 | $-12.7M | $30.8M | ||
| Q1 25 | $-40.5M | $34.1M | ||
| Q4 24 | — | $27.0M | ||
| Q3 24 | $-29.5M | $33.4M | ||
| Q2 24 | $-61.9M | $26.1M | ||
| Q1 24 | $61.0M | $22.4M |
毛利率ESPRUSLM
| Q4 25 | — | 48.0% | ||
| Q3 25 | — | 51.2% | ||
| Q2 25 | — | 45.8% | ||
| Q1 25 | — | 50.6% | ||
| Q4 24 | — | 44.3% | ||
| Q3 24 | — | 48.2% | ||
| Q2 24 | — | 45.5% | ||
| Q1 24 | — | 42.7% |
营业利润率ESPRUSLM
| Q4 25 | 50.6% | 41.0% | ||
| Q3 25 | -11.4% | 45.3% | ||
| Q2 25 | 8.6% | 39.0% | ||
| Q1 25 | -34.0% | 43.7% | ||
| Q4 24 | -6.4% | 38.8% | ||
| Q3 24 | -31.0% | 42.6% | ||
| Q2 24 | 3.5% | 39.1% | ||
| Q1 24 | 52.5% | 35.9% |
净利率ESPRUSLM
| Q4 25 | — | 34.7% | ||
| Q3 25 | -35.9% | 38.0% | ||
| Q2 25 | -15.4% | 33.7% | ||
| Q1 25 | -62.2% | 37.4% | ||
| Q4 24 | — | 33.7% | ||
| Q3 24 | -57.2% | 37.3% | ||
| Q2 24 | -83.9% | 34.0% | ||
| Q1 24 | 44.3% | 31.3% |
每股收益（稀释后）ESPRUSLM
| Q4 25 | $0.32 | $1.06 | ||
| Q3 25 | $-0.16 | $1.35 | ||
| Q2 25 | $-0.06 | $1.07 | ||
| Q1 25 | $-0.21 | $1.19 | ||
| Q4 24 | $-0.14 | $-2.20 | ||
| Q3 24 | $-0.15 | $1.16 | ||
| Q2 24 | $-0.33 | $0.91 | ||
| Q1 24 | $0.34 | $3.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $371.1M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $-302.0M | $630.8M |
| 总资产 | $465.9M | $681.0M |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ESPRUSLM
| Q4 25 | $167.9M | $371.1M | ||
| Q3 25 | $92.4M | $349.5M | ||
| Q2 25 | $86.1M | $319.9M | ||
| Q1 25 | $114.6M | $300.6M | ||
| Q4 24 | $144.8M | $278.0M | ||
| Q3 24 | $144.7M | $255.0M | ||
| Q2 24 | $189.3M | $222.5M | ||
| Q1 24 | $226.6M | $207.0M |
总债务ESPRUSLM
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益ESPRUSLM
| Q4 25 | $-302.0M | $630.8M | ||
| Q3 25 | $-451.4M | $602.3M | ||
| Q2 25 | $-433.5M | $563.3M | ||
| Q1 25 | $-426.2M | $532.2M | ||
| Q4 24 | $-388.7M | $497.7M | ||
| Q3 24 | $-370.2M | $474.2M | ||
| Q2 24 | $-344.2M | $441.1M | ||
| Q1 24 | $-294.3M | $415.3M |
总资产ESPRUSLM
| Q4 25 | $465.9M | $681.0M | ||
| Q3 25 | $364.0M | $652.8M | ||
| Q2 25 | $347.1M | $607.4M | ||
| Q1 25 | $324.0M | $585.3M | ||
| Q4 24 | $343.8M | $543.2M | ||
| Q3 24 | $314.1M | $521.8M | ||
| Q2 24 | $352.3M | $484.2M | ||
| Q1 24 | $373.1M | $464.0M |
负债/权益比ESPRUSLM
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $45.6M |
| 自由现金流经营现金流 - 资本支出 | — | $25.7M |
| 自由现金流率自由现金流/营收 | — | 29.2% |
| 资本支出强度资本支出/营收 | 0.0% | 22.6% |
| 现金转化率经营现金流/净利润 | — | 1.49× |
| 过去12个月自由现金流最近4个季度 | — | $102.3M |
8季度趋势，按日历期对齐
经营现金流ESPRUSLM
| Q4 25 | $45.2M | $45.6M | ||
| Q3 25 | $-4.3M | $45.9M | ||
| Q2 25 | $-31.4M | $34.0M | ||
| Q1 25 | $-22.6M | $39.4M | ||
| Q4 24 | $-35.0M | $38.6M | ||
| Q3 24 | $-35.3M | $39.0M | ||
| Q2 24 | $-7.2M | $21.2M | ||
| Q1 24 | $53.8M | $27.2M |
自由现金流ESPRUSLM
| Q4 25 | — | $25.7M | ||
| Q3 25 | — | $31.3M | ||
| Q2 25 | — | $20.8M | ||
| Q1 25 | — | $24.6M | ||
| Q4 24 | — | $27.6M | ||
| Q3 24 | $-35.5M | $33.9M | ||
| Q2 24 | $-7.3M | $16.8M | ||
| Q1 24 | $53.8M | $20.3M |
自由现金流率ESPRUSLM
| Q4 25 | — | 29.2% | ||
| Q3 25 | — | 30.7% | ||
| Q2 25 | — | 22.7% | ||
| Q1 25 | — | 26.9% | ||
| Q4 24 | — | 34.4% | ||
| Q3 24 | -68.7% | 37.9% | ||
| Q2 24 | -9.9% | 21.9% | ||
| Q1 24 | 39.0% | 28.4% |
资本支出强度ESPRUSLM
| Q4 25 | 0.0% | 22.6% | ||
| Q3 25 | 0.0% | 14.4% | ||
| Q2 25 | 0.0% | 14.5% | ||
| Q1 25 | 0.0% | 16.3% | ||
| Q4 24 | 0.0% | 13.8% | ||
| Q3 24 | 0.3% | 5.8% | ||
| Q2 24 | 0.1% | 5.7% | ||
| Q1 24 | 0.1% | 9.5% |
现金转化率ESPRUSLM
| Q4 25 | — | 1.49× | ||
| Q3 25 | — | 1.18× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.16× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.17× | ||
| Q2 24 | — | 0.81× | ||
| Q1 24 | 0.88× | 1.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
USLM
暂无分部数据
